Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Introduction In this chapter, our goal is to provide a bedside approach to the patient with metabolic acidosis. This approach focuses not only on diagnosing the cause of metabolic acidosis but also (and importantly) on identifying and managing emergencies that are present and anticipating and preventing risks that are likely to arise during therapy. An important component of our approach is to deduce whether there is…
Introduction There are four primary acid–base disturbances, two metabolic and two respiratory. Each of these disorders has an expected compensatory response, which is aimed at minimizing the change in H + ion concentration. These expected responses, unfortunately, must be memorized. Knowing these expected responses helps identify mixed acid–base disorders. As was emphasized in Chapter 1 , the role of buffering in patients with metabolic acidosis is…
Introduction Our goal in this chapter is to describe the physiology of hydrogen ions (H + ) and how acid–base balance is achieved. From a chemical perspective, H + is the smallest ion (atomic weight 1) and its concentration in body fluids is tiny (a million-fold lower than that of its major partner, HCO3− HCO 3 − ). Nevertheless, H + ions are extremely powerful because…
Introduction Primary neoplastic lesions of the kidney can be divided according to the age groups of affected patients. Renal tumors in children generally resemble the nephrogenic tissues of embryogenesis and include nephroblastoma (Wilms tumor) and clear cell sarcoma. Renal cell carcinomas (RCCs) are the major neoplasia of the kidney in adults. They have been classified on the basis of their histologic appearance, but studies have determined…
Introduction Polycystic kidney disease (PKD) is clinically and genetically heterogeneous and is the most common heritable kidney disease. PKD can be inherited either in a dominant or recessive pattern. Cystic kidney disease is a common feature of ciliopathies and is one of the most common causes of end-stage renal disease in both children and adults. Although single simple cysts of the kidney are relatively common and…
Introduction Evaluation of the renal morphology in allograft patients is used to answer two major questions: Is the failure of the graft caused by rejection or some other unrelated lesion? And if rejection is present, what immune mechanism(s) is (are) the cause, and is the lesion potentially reversible using available therapeutic approaches? In the absence of evidence of rejection, it should be ascertained whether the graft…
Introduction Chronic or end-stage kidney disease can result from widely divergent causes, such as glomerular, vascular, and tubulointerstitial diseases. The use of the formulaic estimated glomerular filtration rate (eGFR) is now a standard practice, and this has resulted in the identification of patients at risk for end-stage disease early in the disease course. A chronic kidney disease staging system based on eGFR is routinely applied. A…
Introduction Chronic kidney disease (CKD) is a worldwide public health problem affecting approximately 10% to 13% of the population in developed countries, where diabetes mellitus and hypertension are the leading causes of CKD. In developing countries, the percentage of patients with CKD not caused by diabetes or hypertension is considerably higher than in developed countries. The higher proportion of CKD in these countries could be the…
Introduction The tubulointerstitial compartment is affected in all forms of renal disease with changes that include tubular epithelial injury, atrophy, hypertrophy/hyperplasia, and fibrosis. These changes can be primary, with the tubule and interstitium as the target of damage, but they are often secondary to glomerular or vascular disease, where tubular atrophy and interstitial scarring accompany the primary glomerular or vascular disease. This chapter is focused on…
Diabetic nephropathy The classic patient with diabetic nephropathy (DN) typically presented with gradual progression of disease from microalbuminuria to proteinuria, usually about 15 years after onset of diabetes. Renal lesions are quite similar in type I and type II diabetes mellitus (DM), although the delay in clinical diagnosis of type II DM may give the appearance of shorter interval to DN in these patients. Patients with…
Primary glomerular diseases Glomerular diseases that cause nephrotic syndrome: Nonimmune complex Minimal change disease and focal segmental glomerulosclerosis: Introduction Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) both typically present as nephrotic syndrome and cannot be readily distinguished based solely on clinical presentation. Approximately 90% of children ages 1 to 7 years with nephrotic syndrome appear to have MCD, and the vast majority respond to…
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Objectives This chapter will: 1. Describe the role of renin-angiotensin system (RAS) and angiotensin receptor blockers (ARBs) as risk factors of renal impairment in everyday clinical practice. 2. Describe the role of angiotensin-converting enzyme inhibitors (ACEIs) and ARBs in the treatment of acute and chronic kidney dysfunction (CKD). 3. Detail the most important studies describing the risk of acute kidney injury in different subsets of patients…
Objectives This chapter will: 1. Detail the pathophysiology of ischemia/reperfusion injury and hypothermic protection described in experimental evidence. 2. Discuss the limitations of animal models. 3. Describe three clinical scenarios in which hypothermia is used in clinical settings of ischemia reperfusion injury: transplantation, deceased donors, and postcardiac arre s t. The effect of hypothermia on animal models and human physiology have been explored with clear evidence…
Objectives This chapter will: 1. Highlight some of the challenges inherent to studies of acute kidney injury (AKI). 2. Discuss the different renal and nonrenal end points in AKI trials. 3. Discuss methods to improve study outcomes in AKI intervention trials. Challenges Inherent to the Study of Acute Kidney Injury Despite advances in modern medicine, acute kidney injury (AKI) is associated with a heavy burden of…
Objectives This chapter will: 1. Discuss acute kidney injury as a frequent complication in patients with sepsis that is associated with a high risk of mortality. 2. Review our current understanding of the pathophysiology of sepsis-induced acute kidney injury, highlighting the potential role of renal tissue ischemia and hypoxia. 3. Evaluate the renal effects of commonly used vasopressor drugs to restore blood pressure in patients with…
Objectives This chapter will: 1. Describe the issues with and treatment options for critical care patients with anemia. 2. Discuss the risks and benefits of transfusions versus erythropoiesis-stimulating agents (ESAs) treatment. 3. Present results of clinical trials of critical care patients treated with ESAs. 4. Evaluate hypotheses associated with organ protection by ESAs. Anemia and Transfusion in the Intensive Care Unit U.S. studies report that almost…
Objectives This chapter will: 1. Review the mechanism of action, indications, biologic effects, and complications associated with statin treatment. 2. Discuss the role of statin treatment in chronic kidney disease patients. 3. Examine the evidence for statin use in patients for prevention or treatment of sepsis-associated, postoperative, and contrast-induced acute kidney injury. One in four patients 40 years or older in the United States reports using…
Objectives This chapter will: 1. Discuss the mechanisms of the renal toxicity related to heavy metals exposure. 2. Describe the clinical features of poisoning by heavy metals. 3. Analyze the therapeutic approaches to heavy metal intoxication. Heavy metals are chemical elements with a specific gravity that is five times the specific gravity of water (1°–4°C). Specific gravity is a measure of density of a given amount…